Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Hepatology

• Publication date

  1996-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/JHEP.1996.V24.PM0008938167PMID 8938167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International normalized ratio.

  1998cited by this paper
• Acute liver failure.

  1995cited by this paper
• The international normalized ratio. A guide to understanding and correcting its problems.

  1994cited by this paper
• Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.

  1994cited by this paper
• The International Normalized Ratio (INR) for Monitoring Warfarin Therapy: Reliability and Relation to Other Monitoring Methods

  1994cited by this paper
• Assessment of the Validity of the INR System for Patients with Liver Impairment

  1994cited by this paper
• The International Normalized Ratio.

  1994cited by this paper
• Primary biliary cirrhosis: Prediction of short‐term survival based on repeated patient visits

  1994cited by this paper
• The role of transjugular liver biopsy in fulminant liver failure: Relation to other prognostic indicators

  1993cited by this paper
• Prothrombin time in fulminant hepatic failure.

  1991influential reference
• Fulminant Hepatic Failure and Orthotopic Liver Transplantation

  1989cited by this paper
• Prognosis in primary biliary cirrhosis: Model for decision making

  1989cited by this paper
• Early indicators of prognosis in fulminant hepatic failure.

  1989cited by this paper
• Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.

  1989cited by this paper
• Liver transplantation in the management of fulminant hepatic failure.

  1989cited by this paper
• Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

  1988cited by this paper
• Orthotopic liver transplantation for acute and subacute hepatic failure in adults

  1987cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• International Committee for Standardization in Haematology International Committee on Thrombosis and Haemostasis

  1985cited by this paper
• ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.

  1985cited by this paper

• Association between prothrombin time activity and short-term outcomes in patients with infective endocarditis

  2026cites this paper
• Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders

  2025cites this paper
• ‘Fulminant hepatic failure’ anesthesiologic considerations

  2025cites this paper
• Stratifying and predicting progression to acute liver failure during the early phase of acute liver injury

  2025cites this paper
• Quality standards for the management of alcohol-related liver disease: consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology ARLD special interest group

  2023cites this paper
• Association between admission prothrombin time activity and hospital readmission in heart failure: a retrospective study.

  2023cites this paper
• Glycoprotein non-metastatic melanoma protein B expression correlates with the prognosis of acute liver injury/failure

  2023cites this paper
• Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B.

  2023cites this paper
• UTILITY OF THE PRODUCT VALUE OF SERUM ALBUMIN AND PROTHROMBIN TIME IN ASSESSING THE SEVERITY OF ACUTE PANCREATITIS

  2023cites this paper
• Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder.

  2023cites this paper
• Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?

  2022cites this paper
• Indications for the Use of Therapeutic Plasma in Adult Patients

  2022cites this paper
• Alleviation of hepatotoxicity by natural chelators in lead-induced poisoning in rats

  2022cites this paper
• Early prediction of decompensation (EPOD) score: Non‐invasive determination of cirrhosis decompensation risk

  2022cites this paper
• Transcatheter arterial steroid injection therapy improves the prognosis of patients with acute liver failure

  2022cites this paper
• Early‐phase prothrombin time‐international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement

  2022cites this paper
• The Mortality Index for Alcohol-Associated Hepatitis: A Novel Prognostic Score.

  2022cites this paper
• Differences in Inflammatory Parameters of Child-Pugh B and Child-Pugh C Scores of Liver Cirrhosis with Hepatorenal Syndrome

  2021cites this paper
• Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China

  2021cites this paper
• The Combination of Nucleotide Analog Therapy and Steroid Pulse Therapy for Acute HBV Infection Effectively Promotes HBV Clearance

  2021cites this paper
• Alkaloidal Extract From Carica papaya Seeds Ameliorates CCl 4-Induced Hepatocellular Carcinoma in Rats

  2021cites this paper
• Clinical Considerations of Coagulopathy in Acute Liver Failure

  2020cites this paper
• Hemorrhagic disorders and laboratory assessment

  2020cites this paper
• Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease

  2020cites this paper
• A Multi-Centered Case Series Highlighting the Clinical Use and Dosing of Lidocaine and Mexiletine for Refractory Cancer Pain

  2020cites this paper
• The role of pre-surgical INR testing in dental patients with liver diseases

  2020cites this paper
• Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.

  2020cites this paper
• How Good is Jarzynski’s Equality for Computer-Aided Drug Design?

  2020cites this paper
• Graft-to-Recipient Weight Ratio Associated With Tacrolimus Metabolism Following Pediatric Living Donor Liver Transplantations.

  2019cites this paper
• Predicting Future Complications of Cirrhosis

  2019cites this paper
• The product value of serum albumin and prothrombin time activity could be a useful biomarker for severity prediction in AP: An ordinal retrospective study.

  2019cites this paper
• The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management

  2018cites this paper
• Risk factors of bilateral chronic subdural hematoma compared to unilateral chronic subdural hematoma

  2018cites this paper
• Prognostic Scores in Alcoholic Hepatitis 1 PREDICTING OUTCOME IN ALCOHOLIC HEPATITIS : PERFORMANCE AND APPLICATION OF EXISTING PROGNOSTIC SCORES IN THE STOPAH TRIAL

  2018cites this paper
• Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.

  2018cites this paper
• Coagulation in chronic liver disease and the use of prothrombin complex concentrate for an emergent procedure: a case report and review of literature

  2018cites this paper
• Selective visceral perfusion improves renal flow and hepatic function in neonatal aortic arch repair.

  2018cites this paper
• Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.

  2017cites this paper
• Review article: recent insights into clinical decision‐making in severe alcoholic hepatitis

  2017cites this paper
• Development and validation of a prognostic nomogram for acute‐on‐chronic hepatitis B liver failure

  2017cites this paper
• Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis.

  2017cites this paper
• Comparison of patients with fulminant versus near-miss fulminant druginduced hepatitis

  2017cites this paper
• Coagulation in acutely ill patients with severe chronic liver disease: Insights from thromboelastography☆

  2017cites this paper
• Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

  2016cites this paper
• Impact of an Institutional Change in Prothrombin Time Methodology on INR and MELD Scores in Liver Transplant Evaluations

  2016cites this paper
• Impact of Inter-Laboratory Variability on Model of End-Stage Liver Disease (MELD) Score Calculation.

  2016cites this paper
• Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study

  2016cites this paper
• Применение КТ-волюметрии и клиренс-теста с индоцианином зеленым для определения показаний к предоперационной эмболизации воротной вены

  2016cites this paper
• The INR is only one side of the coagulation cascade: time to watch the clot

  2016cites this paper
• Biomarkers in Hepatic Disease

  2016cites this paper
• Correlation between circulating miR‐122 and prognosis of chronic HBV‐related liver failure

  2016cites this paper
• Approach to Impaired Liver Function Tests

  2016cites this paper
• Standard liver tests

  2016cites this paper
• Activated protein C retards recovery from coagulopathy in severe acute pancreatitis

  2016cites this paper
• Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

  2015cites this paper
• Prognostic models for alcoholic hepatitis

  2015cites this paper
• USEFULNESS OF MELD SCORE IN PREDICTING IN - HOSPITAL MORTALITY IN PAT I ENTS WITH END STAGE LIVER DISEASE: AN OBSERVATIONAL STUDY

  2015cites this paper
• Model for End stage Liver Disease (MELD) and Child-Turcotte-Pugh (CTP) scores: Ability to predict mortality and removal from liver transplantation waiting list due to poor medical conditions.

  2014cites this paper
• Predicting Short-Term Mortality and Long-Term Survival for Hospitalized US Patients with Alcoholic Hepatitis

  2014cites this paper
• Usefulness and accuracy of the international normalized ratio and activity percent of prothrombin time in patients with liver disease

  2014cites this paper
• IMPACT OF POLYMORPHISMS IN THE ENDOBIOTIC AND XENOBIOTIC METABOLISM INVOLVED ENZYMES CODING GENES ON CHRONIC HEPATITIS C AND ACUTE TOXIC HEPATITIS

  2014cites this paper
• Venous Thromboembolism in Cirrhosis

  2014cites this paper
• National Transplant Data Registries and Population Studies

  2014cites this paper
• IMPACT OF POLYMORPHISMS IN THE ENDOBIOTIC AND XENOBIOTIC METABOLISM INVOLVED ENZYMES CODING GENES ON CHRONIC HEPATITIS C AND ACUTE TOXIC ALCOHOL INDUCED HEPATITIS

  2014cites this paper
• Semiparametric Prediction, Variable Importance, and Effect Estimation in Critical Care

  2014cites this paper
• The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.

  2013cites this paper
• CHILDREN WITH LIVER DISEASE

  2013cites this paper
• Important predictor of mortality in patients with end-stage liver disease

  2013cites this paper
• Coagulation in children with liver disease

  2013cites this paper
• Transiently increased variation between a Point-of-Care and laboratory INR method after a long period of correlation: a case study demonstrating the need for ongoing correlation of POC with the central laboratory.

  2013cites this paper
• Liver function testing with nuclear medicine techniques is coming of age.

  2012cites this paper
• Alteraciones de la coagulación en cirrosis, viejos y nuevos paradigmas

  2012cites this paper
• Coagulopathy: Pathophysiology, Evaluation, and Treatment

  2012cites this paper
• Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis

  2012cites this paper
• The influence of laboratory‐induced MELD score differences on liver allocation: more reality than myth

  2012cites this paper
• Old and new paradigms for cirrhosis associated coagulation abnormalities

  2012cites this paper
• Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease

  2012cites this paper
• The MELD Score: Limitations and consequences.

  2012cites this paper
• Development of a sensitive prognostic scoring system for the evaluation of severity of acute-on-chronic hepatitis B liver failure: a retrospective cohort study.

  2012cites this paper
• Does model for end-stage liver disease (MELD) require modification?

  2011cites this paper
• Controversies in Liver Transplantation

  2011cites this paper
• Initial laboratory predictors of severe hepatitis and acute kidney injury in patients with acute hepatitis A.

  2011cites this paper
• PROTHROMBIN TIME AS AN INDICATOR OF SEVERITY OF LIVER DISEASES

  2011cites this paper
• CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation

  2011cites this paper
• Does model for end-stage liver disease (MELD) require modification?

  2011cites this paper
• Assessment of Liver Function

  2011cites this paper
• A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.

  2011cites this paper
• Evaluation of Liver Function

  2011cites this paper
• Laboratorijska dijagnostika bolesti jetre Laboratory diagnosis of liver disease

  2011cites this paper
• A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure.

  2011cites this paper
• Direct international normalized ratio determination using multicalibrators is more responsive than the conventional method for measuring prothrombin time

  2010cites this paper
• Assessment of validity of INR system for patients with liver disease associated with viral hepatitis

  2010cites this paper
• Thromboplastin standards.

  2010cites this paper
• Predictive parameters after molecular absorbent recirculating system treatment integrated with model for end stage liver disease model in patients with acute-on-chronic liver failure.

  2010cites this paper
• Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease

  2010cites this paper
• A double‐blind, randomized, placebo‐controlled trial of intravenous l‐ornithine–l‐aspartate on postural control in patients with cirrhosis

  2010cites this paper
• Haemostasis and thrombosis in liver disease

  2010cites this paper
• Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays

  2010cites this paper
• The International Normalized Ratio (INR) in the MELD Score: Problems and Solutions

  2010cites this paper
• Rôle du foie dans l'hémostase

  2010cites this paper